No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
178 |
4. Check minimum number of eventsNone |
178 |
5. Include endpointsNone |
178 |
6. Filter based on genotype QC (FinnGen only) |
178 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_NERVOUS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q0
- Name in latin
- Aliae malformationes congenitae encephali
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of brain
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the nervous system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2987 | 1324 | 1657 |
| Only index persons | 2131 | 981 | 1150 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.05 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 5.21 | 6.59 | 3.95 |
| Only index persons | 9.59 | 12.95 | 6.73 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 178 | 95 | 83 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 29.98 | 32.46 | 27.15 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 162
- Matched controls
- 1622
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
+∞
77.4
68
*
Q04.6
ICD-10 Finland
Congenital cerebral cysts
+∞
51.9
47
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
20.0
40.6
64
51
N03AF02
ATC
oxcarbazepine; oral
17.9
26.4
42
31
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
22.4
25.4
37
21
G40.9
ICD-10 Finland
Epilepsy, unspecified
17.5
22.1
35
25
183
Kela drug reimbursment
Lamotrigin and topiramate
27.9
20.8
28
12
N03AX14
ATC
levetiracetam; systemic
15.6
20.6
34
27
Q04.9
ICD-10 Finland
Congenital malformation of brain, unspecified
+∞
19.1
18
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
29.3
18.9
25
10
N05BA09
ATC
clobazam; oral
23.2
17.0
24
12
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.0
16.6
44
82
G93.0
ICD-10 Finland
Cerebral cysts
37.7
16.2
20
6
Q04.3
ICD-10 Finland
Other reduction deformities of brain
+∞
15.9
15
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
18.5
15.8
24
15
N03AX11
ATC
topiramate; oral
14.5
15.5
26
21
N03AG01
ATC
valproic acid; systemic, rectal
7.4
14.6
36
60
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
47.2
14.4
17
*
Q04.00
ICD-10 Finland
Agenesis of corpus callosum
+∞
13.7
13
*
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
17.0
13.5
21
14
AA1AD
NOMESCO Finland
CT of head and brain
4.7
12.8
49
138
N05CD08
ATC
midazolam; nasal, systemic
11.5
12.5
23
23
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.3
12.4
34
65
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
23.4
10.9
15
7
XA800
NOMESCO Finland
Neuropsychological investigation
5.5
10.0
30
64
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.0
9.8
27
52
N05BA01
ATC
diazepam; systemic, rectal
4.5
9.5
35
93
R62.0
ICD-10 Finland
Delayed milestone
7.3
9.3
22
34
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
16.9
9.2
14
9
N03AX09
ATC
lamotrigine; oral
5.7
8.8
25
50
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.5
8.6
31
81
F83
ICD-10 Finland
Mixed specific developmental disorders
7.2
8.5
20
31
AAJ20
NOMESCO Finland
Excision of epileptic focus
+∞
8.4
8
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
+∞
8.4
8
*
Q04.08
ICD-10 Finland
Congenital malformations of corpus callosum
+∞
8.4
8
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.5
8.3
21
36
F82
ICD-10 Finland
Specific developmental disorder of motor function
9.7
8.3
16
18
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
18.4
8.2
12
7
H47.2
ICD-10 Finland
Optic atrophy
35.3
8.2
10
*
G40.10
ICD-10 Finland
Simple partial seizures
23.4
8.1
11
5
N03AX18
ATC
lacosamide; systemic
14.0
8.0
13
10
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
47.3
7.8
9
*
N03AX15
ATC
zonisamide; oral
19.5
7.7
11
6
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.1
7.4
29
82
P85
ICPC
Mental retardation
16.7
7.3
11
7
N03AG04
ATC
vigabatrin; oral
21.2
7.2
10
5
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
21.2
7.2
10
5
N03AF01
ATC
carbamazepine; oral, rectal
7.0
6.8
16
25
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
41.9
6.8
8
*
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
41.9
6.8
8
*
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
41.9
6.8
8
*
N03AX22
ATC
perampanel; oral
23.7
6.7
9
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
13.0
6.7
11
9
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.9
6.5
42
172
N03AX23
ATC
brivaracetam; systemic
72.6
6.5
7
*
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
72.6
6.5
7
*
H52.2
ICD-10 Finland
Astigmatism
8.7
6.5
13
16
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
6.5
52
244
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.7
6.4
27
82
181
Kela drug reimbursment
Retigabine and vigabatrin
18.9
6.3
9
5
Z2445
NOMESCO Finland
Psychologist
3.8
6.3
26
77
G40.89
ICD-10 Finland
Other epilepsy
27.9
6.3
8
*
AAF40
NOMESCO Finland
Shunt of cyst of brain to peritoneum
+∞
6.3
6
*
Q04.4
ICD-10 Finland
Septo-optic dysplasia
+∞
6.3
6
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
6.1
67
369
H50.0
ICD-10 Finland
Convergent concomitant strabismus
10.6
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3024561) Albumin [Mass/volume] in Serum or Plasma
81
486
2.22
6.28
5.2
6.7
g/l
37.6
36.8
0.80
76
466
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
96
628
2.15
5.87
12.6
11.0
mmol/l
1.2
1.2
0.05
86
563
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
64
368
2.15
5.36
1.5
1.7
pmol/l
106.5
95.9
0.77
35
192
(3019550) Sodium [Moles/volume] in Serum or Plasma
163
1368
3.27
5.04
19.0
13.3
mmol/l
139.1
139.6
1.38
157
1325
(3023103) Potassium [Moles/volume] in Serum or Plasma
162
1371
3.02
4.61
17.6
13.3
mmol/l
4.0
4.0
0.62
155
1323
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
5
14.49
4.61
2.9
2.8
umol/l
26.3
16.4
—
7
5
(3019309) Folate [Moles/volume] in Red Blood Cells
26
112
2.55
4.16
1.3
1.4
nmol/l
1222.2
1120.6
0.24
18
89
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
7
7
10.34
4.04
2.6
3.3
umol/l
19.7
22.6
—
7
7
(3013336) Amino acids [Identifier] in Serum or Plasma
7
8
9.05
3.80
2.1
4.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
165
1447
2.92
3.67
10.8
9.1
u/l
27.6
26.7
0.27
160
1404
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
101
2.47
3.54
6.8
5.2
—
—
—
0
0
(3049233) Organic acids panel - Urine
6
7
8.81
3.29
1.3
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
61
399
1.80
3.27
2.2
3.1
mmol/l
2.4
2.4
0.14
54
355
(3021960) Folate [Moles/volume] in Serum or Plasma
40
228
1.97
3.27
1.7
1.4
nmol/l
24.3
22.3
0.28
35
201
(3023520) Reticulocytes [#/volume] in Blood
22
100
2.37
3.15
2.9
4.9
e9/l
57.4
71.3
1.44
12
73
(3020717) Zinc [Moles/volume] in Serum or Plasma
9
21
4.45
3.04
1.8
1.9
umol/l
12.2
16.0
—
9
21
(40758558) Short blood count panel - Blood
63
425
1.75
3.01
5.3
8.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
46
2.97
2.99
2.9
9.7
%
45.0
51.5
0.32
13
46
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
30
162
2.02
2.84
2.1
2.7
mmol/l
2.4
2.4
0.69
24
141
(3013650) Neutrophils [#/volume] in Blood by Automated count
111
886
1.67
2.75
8.5
10.8
e9/l
3.8
3.7
0.06
95
752
(3001604) Monocytes [#/volume] in Blood
102
797
1.66
2.74
7.8
7.4
e9/l
0.6
0.6
0.11
85
680
(3006315) Basophils [#/volume] in Blood
102
800
1.64
2.68
7.8
7.4
e9/l
0.0
0.0
0.18
85
685
(3021589) Normoblasts [#/volume] in Blood
94
723
1.64
2.66
8.7
10.0
e9/l
0.0
0.0
0.49
74
559
(3018418) pH of Serum or Plasma
48
310
1.75
2.63
5.2
3.6
ph
7.4
7.4
0.54
11
44
(3019198) Lymphocytes [#/volume] in Blood
104
823
1.63
2.61
7.7
7.4
e9/l
2.3
2.2
0.28
87
720
(3010015) Selenium [Moles/volume] in Serum or Plasma
6
11
5.60
2.56
2.5
2.4
umol/l
1.1
1.1
—
6
11
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
83
2.30
2.51
2.1
3.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
13
51
2.67
2.50
1.5
4.3
mg/l
426.2
429.9
0.01
13
51
(3002032) Base excess in Venous blood by calculation
33
195
1.85
2.41
7.3
11.6
mmol/l
0.9
1.1
0.15
27
144
(3007853) Bacteria identified in Skin by Aerobe culture
29
166
1.89
2.33
1.8
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
103
827
1.58
2.33
8.0
8.1
e9/l
0.2
0.2
1.64
88
716
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
490
0.56
2.32
1.8
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
47
2.67
2.32
1.6
5.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
13
4.73
2.29
2.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
18
4.00
2.27
1.4
3.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
305
1.69
2.27
2.3
2.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
19
3.79
2.17
2.0
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
18
89
2.14
2.14
2.3
2.0
iu/l
17.2
18.9
0.07
11
69
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
83
2.16
2.09
2.3
2.1
u/l
7.9
7.7
—
10
62
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
128
1096
1.60
2.08
9.6
8.5
ml/min/173m2
101.0
93.6
2.32
108
829
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
28
165
1.83
2.06
1.5
1.4
pmol/l
549.7
447.1
0.62
21
144
(3000991) Gas panel - Venous blood
31
189
1.78
2.05
8.7
12.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
56
401
1.58
2.02
2.6
2.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
136
1.88
1.99
2.3
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
21
3.43
1.98
2.7
5.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
11
4.64
1.95
1.2
1.6
mmol/l
1.7
1.5
—
5
11
(3051651) Icteric interference index of Serum or Plasma
6
16
3.84
1.95
1.5
3.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
72
2.18
1.92
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
306
0.51
1.92
1.5
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
40
267
1.64
1.91
3.1
4.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
124
1067
1.53
1.85
3.9
3.7
pmol/l
14.5
14.4
0.07
113
993
(40761511) CBC panel - Blood by Automated count
163
1506
1.98
1.77
14.6
9.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
23
136
1.79
1.69
3.3
4.0
g/l
0.2
0.2
0.20
23
129
(4035726)
18
99
1.91
1.64
1.1
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
109
926
1.46
1.63
7.5
6.4
u/l
97.3
98.2
0.04
101
866
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
29
186
1.67
1.61
2.3
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
26
2.76
1.59
1.7
6.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
6
20
3.07
1.59
6.2
2.2
mosm/kgh2o
289.7
289.8
—
6
13
(3020891) Body temperature
10
44
2.35
1.56
10.1
7.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
15
3.40
1.53
2.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
15
3.40
1.53
1.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
141
1.72
1.51
2.4
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
16
3.18
1.45
1.8
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
69
549
1.42
1.43
8.6
8.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
139
1255
1.49
1.39
4.2
4.2
mu/l
1.8
2.9
0.59
124
1173
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
23
2.66
1.38
1.2
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
43
315
1.48
1.37
3.7
3.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
17
2.99
1.37
2.4
7.9
%
97.6
99.1
—
5
17
(40761535) Cells panel - Urine sediment
14
77
1.89
1.29
3.0
3.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
127
1134
1.42
1.29
4.2
3.4
mmol/l
5.6
5.7
0.60
114
1048
(3013512) EKG study
34
240
1.52
1.29
3.6
2.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
29
198
1.56
1.27
19.9
15.7
mmol/l
23.5
24.8
1.88
29
198
(3006504) Eosinophils/100 leukocytes in Blood
91
771
1.37
1.26
7.8
7.4
%
2.6
3.0
1.24
86
723
(3014007) Fractional oxyhemoglobin in Arterial blood
11
56
2.03
1.25
11.1
16.2
%
92.9
94.6
0.25
11
56
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
19
2.68
1.22
2.0
3.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
126
0.46
1.22
1.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
15
87
1.79
1.19
4.1
5.4
%
0.5
0.5
—
6
16
(3035350) Ketones [Presence] in Urine by Test strip
77
641
1.35
1.17
4.5
3.2
estimate
0.0
0.0
0.00
12
112
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
80
1.81
1.16
1.6
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
15
88
1.77
1.15
4.3
5.8
%
0.0
0.2
—
7
22
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
155
1448
1.55
1.13
15.0
11.4
mg/l
25.1
22.2
0.47
123
1044
(3035637) Corticotropin [Mass/volume] in Plasma
10
51
2.02
1.13
2.1
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
43
330
1.40
1.07
4.5
2.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
45
2.05
1.06
2.2
3.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
49
385
1.38
1.06
8.4
5.3
inr
1.2
1.2
0.00
17
106
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
26
181
1.51
1.06
2.7
3.2
%
21.1
20.5
0.07
11
64
(3029937) Albumin [Presence] in Urine by Test strip
42
322
1.40
1.05
5.7
3.4
estimate
0.0
0.0
0.50
12
115
(3004588) Protein electrophoresis panel - Serum or Plasma
7
34
2.10
1.04
1.1
2.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
16
99
1.68
1.04
4.2
5.4
%
0.5
0.8
—
8
28
(1616796) Gas panel - Central venous blood
5
22
2.31
1.04
11.4
5.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
76
642
1.32
1.02
6.1
4.6
estimate
0.0
0.0
0.00
12
117
(4034850)
7
35
2.04
1.01
7.0
6.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
46
361
1.37
1.00
4.2
2.7
ng/l
17.2
42.3
0.85
30
182
(3023410) Appearance of Cerebral spinal fluid
7
37
1.93
0.95
1.6
5.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
27
2.26
0.94
1.7
1.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
16
102
1.62
0.94
10.1
15.8
kpa
14.2
13.6
0.17
16
97
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
16
102
1.62
0.94
10.3
15.8
kpa
5.4
5.2
0.21
16
96
(3022313) Gas panel - Capillary blood
24
169
1.49
0.93
15.1
9.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
76
649
1.30
0.93
4.7
3.2
estimate
0.0
0.0
0.00
13
113
(3037522) Nuclear Ab [Titer] in Serum
26
187
1.46
0.92
1.3
1.5
titre
470.0
378.3
—
8
35
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
26
187
1.46
0.92
16.8
9.6
mmol/l
0.2
1.2
0.73
19
138
(3044889) 12 lead EKG panel
88
767
1.29
0.92
3.1
2.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
71
1.74
0.91
1.2
1.3
—
—
—
0
0
(3015736) pH of Urine
61
507
1.31
0.90
3.5
3.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
38
295
1.37
0.88
3.9
3.0
kg/l
1.0
1.0
—
10
42
(3025159) Blasts/100 leukocytes in Blood
14
88
1.64
0.87
4.4
5.8
%
0.0
0.1
—
7
19
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
31
1.97
0.85
1.5
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
171
1658
1.80
0.81
23.5
16.7
e12/l
4.5
4.6
1.31
165
1601
(3010813) Leukocytes [#/volume] in Blood
171
1659
1.78
0.81
23.5
16.8
e9/l
6.6
6.7
0.17
166
1600
(3049717) Cytology report of Urine Cyto stain
0
24
0.00
0.80
0.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
25
0.00
0.79
0.0
1.5
—
7.4
—
0
18
(3035933) Granulocytes/100 leukocytes in Blood
0
26
0.00
0.79
0.0
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
12
184
0.63
0.79
1.5
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
57
480
1.28
0.75
4.9
3.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
55
1.67
0.75
2.7
1.6
—
—
—
0
0
(44806118)
5
26
1.95
0.71
1.2
2.2
—
—
—
0
0
(44790047)
5
26
1.95
0.71
1.2
2.2
—
—
—
0
0
(44790048)
5
26
1.95
0.71
1.2
2.2
—
—
—
0
0
(44790049)
5
26
1.95
0.71
1.2
2.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
101
915
1.24
0.70
3.8
3.5
u/l
44.4
38.4
0.32
91
881
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
27
1.88
0.69
3.6
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
28
1.81
0.66
1.0
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
28
1.81
0.66
1.0
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
22
164
1.39
0.66
3.7
2.7
g/l
2.5
2.5
0.14
22
152
(3011288) Drugs identified in Urine by Screen method
12
79
1.56
0.64
1.7
2.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
52
442
1.25
0.63
1.9
1.9
—
—
—
0
0
(4094501)
5
30
1.69
0.62
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
30
1.69
0.62
1.8
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
306
0.75
0.61
1.5
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
53
1.53
0.59
13.5
13.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
53
1.53
0.59
2.8
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
31
249
1.30
0.59
2.6
2.4
ug/g
284.9
77.1
1.18
23
197
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.3
—
32.2
—
0
17
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
119
1267
0.82
0.58
3.6
3.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
35
1.74
0.58
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
55
1.48
0.57
1.6
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
242
1.29
0.56
2.9
3.7
mg/mmol
2.8
8.4
1.61
19
161
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
157
0.68
0.54
1.6
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
6
39
1.56
0.53
1.0
1.1
—
58.8
—
0
10
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
30
244
1.28
0.53
4.0
3.3
e6/l
0.5
0.6
0.38
14
139
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
236
1.27
0.51
5.1
3.3
e6/l
0.8
2.0
1.02
13
132
(3034770) Mitochondria Ab [Titer] in Serum
7
46
1.54
0.49
1.1
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
49
1.45
0.46
1.6
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
38
324
1.22
0.45
8.6
5.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
51
1.39
0.44
2.1
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
20
158
1.30
0.44
2.8
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
65
585
1.18
0.44
4.1
4.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
32
375
0.82
0.42
2.8
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
52
461
1.18
0.42
6.2
3.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
16
0.00
0.41
0.0
2.3
—
7.3
—
0
11
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
34
1.48
0.40
1.8
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.7
—
0.1
—
0
6
(3019225) pH of Specimen
12
89
1.37
0.39
2.9
3.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
114
0.69
0.38
1.4
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
50
447
1.16
0.36
1.4
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
54
486
1.16
0.36
7.6
4.2
e6/l
128.3
45.1
0.56
36
332
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
42
1.44
0.36
1.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
43
1.41
0.35
3.7
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
133
0.74
0.35
5.1
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
45
1.34
0.34
3.7
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
41
459
0.86
0.32
2.4
2.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
56
1.26
0.30
1.4
1.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
15
121
1.26
0.29
2.6
2.1
nmol/l
8.3
13.4
—
10
110
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
57
1.24
0.29
1.4
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
129
0.76
0.29
1.4
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
64
1.26
0.28
1.4
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
142
1378
1.15
0.27
18.9
15.0
g/l
334.7
334.7
0.03
142
1370
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
197
1.19
0.27
1.7
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
27
235
1.18
0.27
2.7
3.1
mg/l
28.0
630.4
0.95
18
158
(3041096) Erythrocytes [Presence] in Urine by Automated
39
350
1.15
0.27
4.8
2.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
74
1.23
0.25
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
11
137
0.79
0.25
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
52
479
1.12
0.25
1.2
1.5
u/ml
1.2
1.1
0.05
17
104
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.23
4.4
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
38
1.32
0.23
1.0
2.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
39
1.29
0.23
1.8
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
94
0.73
0.23
1.4
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
40
1.26
0.22
1.8
1.3
—
13.4
—
0
7
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
41
1.23
0.22
3.2
5.1
umol/l
4.8
16.3
—
5
35
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
109
1049
1.10
0.22
4.9
4.2
mmol/mol
35.7
37.9
2.64
100
989
(3030467) Casts [#/volume] in Urine by Automated count
42
385
1.12
0.21
6.2
3.6
e6/l
0.3
0.4
0.18
32
286
(3037467) Urinalysis macro (dipstick) panel - Urine
95
909
1.10
0.21
6.0
3.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
83.5
—
0
11
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
212.4
—
0
11
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
21.3
—
0.6
—
0
10
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
8.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
112
0.79
0.20
2.0
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
48
445
1.11
0.20
1.7
1.6
g/l
1.9
2.0
0.23
26
257
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
49
1.23
0.20
4.2
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
12
99
1.23
0.20
9.0
3.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
122
0.81
0.20
1.7
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
51
1.18
0.19
8.8
24.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
120
1164
1.09
0.19
4.0
3.7
mmol/l
1.4
1.5
0.77
113
1095
(40768443) Skin Pathology biopsy report
6
53
1.14
0.19
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
53
1.14
0.19
1.0
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
20
226
0.87
0.18
2.1
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
117
1135
1.09
0.18
3.7
3.5
mmol/l
1.2
1.3
0.30
109
1072
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
121
1176
1.09
0.18
4.1
3.8
mmol/l
4.5
4.7
0.73
114
1114
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
61
1.15
0.18
2.0
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
70
0.71
0.17
1.4
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
75
0.79
0.16
3.2
2.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
121
1179
1.08
0.16
4.2
3.9
mmol/l
2.7
2.8
0.28
113
1112
(3002582) Erythrocytes [#/volume] in Urine
45
422
1.09
0.15
6.6
3.5
e6/l
38.8
32.6
0.09
35
323
(3000494) Fungus identified in Specimen by Culture
13
150
0.86
0.15
1.5
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
103
1.18
0.14
1.0
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
12
103
1.18
0.14
1.3
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
209
1.12
0.14
1.3
1.2
iu/ml
24.7
28.4
—
7
59
(3016879) Cocaine [Presence] in Urine
10
116
0.85
0.12
1.8
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
178
0.89
0.12
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
15
135
1.12
0.10
1.8
2.3
ug/l
0.5
0.6
—
10
71
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
48
1.04
0.09
2.2
2.3
—
—
—
0
0
(1002224) Polysomnography panel
5
62
0.80
0.08
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
164
0.91
0.08
3.9
1.9
—
—
—
0
0
(3000492) Spirometry study
12
133
0.90
0.08
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
76
1.06
0.07
1.6
1.8
—
—
—
0
0
(4010399)
9
83
1.09
0.07
1.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
144
1455
0.95
0.07
16.0
13.7
%
39.9
40.1
0.26
112
1259
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
19
201
0.94
0.05
1.3
1.2
u/ml
4.4
8.0
0.42
11
83
(36304419) Bacteria [Presence] in Urine
40
391
1.03
0.02
6.3
3.5
—
—
—
0
0
(3002256) Pathology report gross observation
12
114
1.06
0.01
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
101
0.99
0.00
1.8
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
21
214
0.98
0.00
1.1
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
26
264
0.98
0.00
2.4
3.8
mg/l
0.7
1.2
0.69
20
212
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
18
181
0.99
0.00
1.9
3.2
ng/l
25.1
427.0
2.04
12
117
(3028300) Cannabinoids [Presence] in Urine
12
123
0.97
0.00
1.7
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
28
275
1.02
0.00
2.9
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
30
305
0.98
0.00
3.0
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
122
0.98
0.00
1.7
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3022670) pH of Venous cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
2.6
—
29.0
—
0
5
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
11.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
6.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
2.6
—
0
6
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
120
1.00
0.00
1.7
1.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
7
69
1.02
0.00
4.3
10.0
g/l
2.9
3.1
—
7
69
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
13.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.3
—
5.3
—
0
6
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
47.0
—
0
5
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(4198724)
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
3.1
—
0
6
(3023511) Choriogonadotropin [Units/volume] in Urine
5
57
0.87
0.00
1.4
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.2
—
45.6
—
0
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
2.7
—
0
7
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
15.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
1857.5
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_BRAIN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_BRAIN | 4.599 [3.29, 6.44] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.067 |
During the follow-up period (1.1.1998 — 31.12.2019), 86 out of 1102 females with Q17_OTHER_CONGEN_MALFO_BRAIN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_BRAIN | 3.755 [2.72, 5.18] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.018 |
During the follow-up period (1.1.1998 — 31.12.2019), 103 out of 1405 males with Q17_OTHER_CONGEN_MALFO_BRAIN died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_BRAIN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.47% | 0.765% |
| 5 | 2.279% | 4.579% |
| 10 | 5.364% | 10.956% |
| 15 | 10.385% | 19.83% |
| 20 | 18.528% | 32.143% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_BRAIN – Other congenital malformations of brain
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data